United States Biotechnology & Medical Research

Entera Bio Ltd (ENTX)

Track

Entera Bio Ltd has seen no insider trading activity within the last three months. The most recent transactions occurred in March 2026, consisting exclusively of open market purchases by various insiders. Prior to this period, there was a consistent pattern of buying activity recorded throughout early 2026 and late 2025.
Ticker: ENTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Entera Bio Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 9 Mar 2026
Value US$4,697,151.79 | Price 18.45 | Shares 25,049 (+22.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-11 2026-03-09 B Purchase
2.9
Germano Geno J
Non-Executive Director
25,049 +22.4%
18.45
US$4,697,152 		25,049 +22.4% 18.45 US$4,697,152
2026-03-09 2026-03-05 B Purchase
2.9
Ellis Sean
Non-Executive Director
91,200 -44.3%
184.55
US$1,955,837 		91,200 -44.3% 184.55 US$1,955,837
2026-02-17 2026-02-12 B Purchase
2.8
Rubin Steven D
Non-Executive Director
76,116 -42.3%
415.64
US$3,253,532 		76,116 -42.3% 415.64 US$3,253,532
2026-02-11 2026-02-09 B Purchase
2.9
Ellis Sean
Non-Executive Director
18,000 +11.2%
1.24
US$22,320 		18,000 +11.2% 1.24 US$22,320
2026-02-11 2026-02-09 B Purchase
2.8
Rubin Steven D
Non-Executive Director
10,000 +inf%
1.20
US$12,000 		10,000 +inf% 1.20 US$12,000
2025-12-30 2025-12-29 B Purchase
3.2
Toledano Miranda Jayne

Chief Executive Officer

Executive Director
11,000 +2.6%
1.81
US$19,912 		11,000 +2.6% 1.81 US$19,912
2024-01-16 2024-01-12 B Purchase
3.7
Taitel Haya
Non-Executive Director
9,500 +37.1%
0.99
US$9,405 		9,500 +37.1% 0.99 US$9,405
2024-01-11 2024-01-10 B Purchase
3.7
Taitel Haya
Non-Executive Director
7,615 +42.3%
0.77
US$5,864 		7,615 +42.3% 0.77 US$5,864
2023-12-27 2023-12-22 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
23,952 +11.8%
0.71
US$17,006 		23,952 +11.8% 0.71 US$17,006
2023-12-27 2023-12-22 B Purchase
3.2
Toledano Miranda Jayne

Chief Executive Officer

Executive Director
23,952 +27.6%
0.71
US$17,006 		23,952 +27.6% 0.71 US$17,006
2023-08-24 2023-08-22 B Purchase
3.7
Taitel Haya
Non-Executive Director
18,000 +inf%
0.62
US$11,216 		18,000 +inf% 0.62 US$11,216
2023-08-23 2023-08-21 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
20,000 +10.3%
0.59
US$11,784 		20,000 +10.3% 0.59 US$11,784
2023-08-22 2023-08-21 B Purchase
2.9
Ellis Sean
Non-Executive Director
40,000 +64.4%
0.60
US$24,000 		40,000 +64.4% 0.60 US$24,000
2023-04-06 2023-04-04 B Purchase
3.2
Toledano Miranda Jayne

Chief Executive Officer

Executive Director
30,000 +52.8%
1.01
US$30,300 		30,000 +52.8% 1.01 US$30,300
2022-11-15 2022-11-14 B Purchase
3.7
Yaacov-Garbeli Dana

Chief Financial Officer

Officer
26,580 +88.6%
0.54
US$14,247 		26,580 +88.6% 0.54 US$14,247
2022-11-15 2022-11-14 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
4,000 +181.8%
0.59
US$2,360 		4,000 +181.8% 0.59 US$2,360
2022-11-15 2022-11-14 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
4,000 +181.8%
0.56
US$2,240 		4,000 +181.8% 0.56 US$2,240
2022-11-15 2022-11-14 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
4,000 +181.8%
0.56
US$2,240 		4,000 +181.8% 0.56 US$2,240
2022-11-15 2022-11-14 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
4,000 +181.8%
0.56
US$2,240 		4,000 +181.8% 0.56 US$2,240
2022-11-15 2022-11-14 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
34,000 +21.2%
0.57
US$19,380 		34,000 +21.2% 0.57 US$19,380
2022-11-15 2022-11-11 B Purchase
3.7
Yaacov-Garbeli Dana

Chief Financial Officer

Officer
30,000 +inf%
0.52
US$15,600 		30,000 +inf% 0.52 US$15,600
2022-11-14 2022-11-11 B Purchase
2.9
Ellis Sean
Non-Executive Director
30,000 +93.5%
0.53
US$15,900 		30,000 +93.5% 0.53 US$15,900
2022-11-14 2022-11-11 B Purchase
3.2
Toledano Miranda Jayne

Chief Executive Officer

Executive Director
50,000 +735.3%
0.53
US$26,585 		50,000 +735.3% 0.53 US$26,585
2022-07-25 2022-07-21 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
19,491 +13.9%
1.68
US$32,803 		19,491 +13.9% 1.68 US$32,803
2022-07-25 2022-07-21 B Purchase
2.9
Ellis Sean
Non-Executive Director
14,900 +86.6%
1.64
US$24,406 		14,900 +86.6% 1.64 US$24,406
2022-01-24 2022-01-20 B Purchase
1.6
Schwartz Phillip

President of R&D

Executive Director
10,000 +1.7%
2.53
US$25,250 		10,000 +1.7% 2.53 US$25,250
2022-01-24 2022-01-19 B Purchase
Ratan Ramesh

U.S.based CFO

Officer
10,000 +inf%
2.44
US$24,364 		10,000 +inf% 2.44 US$24,364
2022-01-24 2022-01-18 B Purchase
0.8
JAMAS SPIROS

Chief Executive Officer

Officer
10,000 +inf%
2.85
US$28,500 		10,000 +inf% 2.85 US$28,500
2022-01-24 2022-01-18 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
700 +46.7%
2.81
US$1,966 		700 +46.7% 2.81 US$1,966
2022-01-24 2022-01-18 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
700 +46.7%
2.78
US$1,949 		700 +46.7% 2.78 US$1,949
2022-01-24 2022-01-18 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
700 +46.7%
2.81
US$1,964 		700 +46.7% 2.81 US$1,964
2022-01-24 2022-01-18 B Purchase
3.7
LIEBERMAN GERALD M
Non-Executive Director
700 +46.7%
2.80
US$1,960 		700 +46.7% 2.80 US$1,960
2022-01-19 2022-01-18 B Purchase
0.8
Mayron Ron
Non-Executive Director
7,000 +inf%
2.80
US$19,600 		7,000 +inf% 2.80 US$19,600
2022-01-19 2022-01-18 B Purchase
2.9
Ellis Sean
Non-Executive Director
10,000 +inf%
2.81
US$28,050 		10,000 +inf% 2.81 US$28,050
2022-01-19 2022-01-14 B Purchase
3.2
Toledano Miranda Jayne
Non-Executive Director
6,800 +inf%
2.79
US$18,971 		6,800 +inf% 2.79 US$18,971
2022-01-25 2022-01-13 B Purchase
0.7
OSTROV GERALD M
Non-Executive Director
10,000 +inf%
2.74
US$27,378 		10,000 +inf% 2.74 US$27,378
2022-01-18 2022-01-13 B Purchase
0.7
Malca Yonatan
Non-Executive Director
7,232 +inf%
2.74
US$19,816 		7,232 +inf% 2.74 US$19,816
Explore more

More insider trading research around Entera Bio Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America